Table 1. Clinical characteristics of enrolled patients (n=24)
No | Sex | Age | Diagnosis | Defect | Flap | Outcome | Re-operation |
1 | M | 59 | SMG ca. | Extraoral | LD | No loss | No |
2 | M | 59 | Nasal cavity ca. | Extraoral | ALT | Partial loss | No |
3 | F | 56 | Supraglottic ca. | Extraoral | DP | Total loss | PMMC |
4 | M | 56 | Glottic ca. | Extraoral | PMMC | No loss | No |
5 | M | 58 | Maxillary sinus ca. | Extraoral | Forehead | No loss | No |
6 | M | 41 | Hard palate ca. | Extraoral | LD | No loss | No |
7 | M | 82 | Eye lid ca. | Extraoral | Forehead | No loss | No |
8 | M | 78 | Hypopharynx ca. | Extraoral | PMMC | No loss | No |
9 | M | 40 | Tongue ca. | Intraoral | FAMM | Partial loss | No |
10 | M | 57 | Tongue ca. | Intraoral | FAMM | No loss | No |
11 | M | 62 | FOM ca. | Intraoral | FAMM | No loss | No |
12 | M | 56 | Buccal ca. | Intraoral | ALT | No loss | No |
13 | M | 31 | RMT ca. | Intraoral | ALT | Partial loss | Re-anastomosis |
14 | M | 69 | Buccal ca. | Intraoral | ALT | Partial loss | Re-anastomosis |
15 | M | 65 | Tongue ca. | Intraoral | ALT | Partial loss | No |
16 | F | 68 | Tongue base ca. | Intraoral | FAMM | No loss | No |
17 | F | 67 | FOM ca. | Intraoral | FFF | Partial loss | No |
18 | M | 70 | RMT ca. | Intraoral | RFF | No loss | No |
19 | F | 62 | Tongue ca. | Intraoral | FAMM | No loss | No |
20 | F | 41 | Maxillary sinus ca. | Intraoral | ALT | Total loss | ALT |
21 | F | 74 | Tongue ca. | Intraoral | FAMM | No loss | No |
22 | M | 46 | Tongue ca. | Intraoral | ALT | Partial loss | No |
23 | F | 56 | Tongue ca. | Intraoral | LD | No loss | No |
24 | M | 36 | Tongue ca. | Intraoral | ALT | Partial loss | No |
ca.: cancer, SMG: submandibular gland, FOM: floor of mouth, RMT: retromolar trigone, CCRT: chemoradiation, LD: latissimus dorsi myocutaneous, ALT: anterolateral thigh, DP: deltopectoral, PMMC: pectoralis major myocutaneous, FAMM: facial artery musculomucosal, FFF: fibula free flap, Re-anastomosis: flap vein thrombosis removal and reanatomosis